ArticleJournal of general internal medicine2025
Use of Antihyperglycemic Medications Among US People with Limited English Proficiency.
Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prescribing Trajectories in Type 2 Diabetes in the United States, 2019-2024.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundLanguage barriers can impact pharmaceutical disease management leading to potential health disparities among limited English proficiency (LEP) people with diabetes mellitus (DM) in the United States (US).
objectiveTo assess the use of antihyperglycemic medications and estimate their impact on glycemic control by LEP status.
designCross-sectional design. We compared the classes of prescribed antihyperglycemic medications and their impact on glycemic control between English-speaking and LEP participants (i.e., Spanish-speaking or needing interpretation services) with DM applying generalized linear models and adjusting for sociodemographic variables.
participantsData from the US National Health and Nutrition Examination Survey (NHANES 2003-2018). MAIN MEASURES: Selected language for interview or interpreter request (main exposure). Outcomes include prescribed antihyperglycemic medications and glycemic control (HBA1c). KEY
resultsData for 4666 participants with DM were analyzed. Antihyperglycemic medications were similarly used by LEP and English-speaking people with DM, except for insulin, which was less frequently used by LEP people. Despite similar medications, LEP people using biguanides and TZDs were less likely to reach glycemic target levels (adjusted odds ratios ranging 1.7 to 3.3) compared to English-speaking people with DM.
conclusionsOur findings indicate that the differences in DM outcomes among LEP people are likely attributed to factors other than medication prescription. These might include cultural beliefs, dietary adjustments, and communication barriers in healthcare. Enhanced patient education, acknowledgment of cultural practices, and improved language services could potentially mitigate these disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.